Workflow
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang
icon
Search documents
证券代码:002124 证券简称:天邦食品 公告编号:2025-060
Group 1 - The company is undergoing a pre-restructuring process as approved by the Ningbo Intermediate People's Court, which does not guarantee that the court will ultimately accept the company's restructuring application [4][54] - The company faces risks of being delisted if the court accepts the restructuring application, as per the Shenzhen Stock Exchange listing rules [2][54] - The company has received formal applications from five industrial investors and two financial investors for restructuring investment [5] Group 2 - The restructuring investment agreements have been signed with multiple financial investors, including Guangzhou Asset Management Co., Ltd., Chengdu Jirui Zeya Enterprise Management Partnership, and Nanchang Yuze Enterprise Management Partnership [6][40] - The total investment amounts from the financial investors include CNY 16.8 million from Guangzhou Asset Management, CNY 38.22 million from Chengdu Jirui, and CNY 49.98 million from Nanchang Yuze, with each investor acquiring shares at a price of CNY 2.10 per share [25][34][41] - The restructuring investment agreements stipulate that the investors will not transfer or delegate their shares for twelve months after acquiring them [48] Group 3 - The restructuring investment is aimed at restoring and improving the company's operational capabilities while protecting the interests of creditors, shareholders, and employees [24][40] - The agreements include provisions for a performance guarantee, where investors must pay a deposit that will convert into part of the investment upon approval of the restructuring plan [26][35][42] - The company anticipates that successful restructuring will improve its financial structure and resolve its debt crisis, thereby enhancing its operational and profitability capabilities [53]
中国石化上海石油化工股份有限公司 2024年年度A股利润分配实施公告
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 扣税后每股现金红利:A股个人股东和证券投资基金股东根据现行有效的税收政策实行现金红利个人 所得税差别化处理;合格境外机构投资者(QFII)股东为0.018元;沪股通香港市场投资者为0.018元。 ● 相关日期 ■ ● 差异化分红送转: 否 一、通过分配方案的股东会届次和日期 中国石化上海石油化工股份有限公司("本公司")2024年度利润分配方案经本公司2025年6月11日的 2024年度股东周年会审议通过。 二、分配方案 1.发放年度:2024年年度 2.发放范围: 截至2025年7月23日(即股权登记日)下午上海证券交易所收市后,在中国证券登记结算有限责任公司 上海分公司(以下简称"中国结算上海分公司")登记在册的本公司全体A股股东。 3.分配方案: 自利润分配方案披露后至本公告日期间,公司注销了已回购的36,264,000股H股股份,总股本由 10,578,881,500股减少至10,542,617,500股。公司按照2024年度利润分配方案中的调整原则, ...
西部证券易储通现金管理型集合资产管理计划2025年第2季度报告提示性公告
Group 1 - The core announcement is regarding the suspension of subscription for the Western Securities Easy Storage Cash Management Collective Asset Management Plan effective from July 17, 2025, to protect the interests of the plan's unit holders [2][3] - The full report for the second quarter of 2025 will be available on the company's website and the China Securities Regulatory Commission's fund electronic disclosure website on July 16, 2025 [1] - During the suspension of subscription, the redemption process for the collective plan will continue to operate normally [4] Group 2 - The management of the collective plan assures that there are no false records, misleading statements, or significant omissions in the report [1] - Investors are encouraged to understand the risk-return characteristics of the collective plan before making investment decisions [4] - The management commits to managing the assets of the collective plan with honesty and diligence but does not guarantee profits or minimum returns [4]
新疆前海联合基金管理有限公司关于以通讯方式召开新疆前海联合添泽债券型证券投资基金基金份额持有人大会的第一次提示性公告
新疆前海联合基金管理有限公司已于2025年7月15日在《中国证券报》及本公司网站 (www.qhlhfund.com)发布了《新疆前海联合基金管理有限公司关于以通讯方式召开新疆前海联合添泽 债券型证券投资基金基金份额持有人大会的公告》。为了使本次基金份额持有人大会顺利召开,根据基 金合同的相关规定,现发布新疆前海联合基金管理有限公司关于以通讯方式召开新疆前海联合添泽债券 型证券投资基金基金份额持有人大会的第一次提示性公告。 一、召开会议基本情况 为保护基金份额持有人的利益,根据《中华人民共和国证券投资基金法》(以下简称"《基金法》")、 《公开募集证券投资基金运作管理办法》和《新疆前海联合添泽债券型证券投资基金基金合同》(以下 简称"《基金合同》")的有关规定,新疆前海联合添泽债券型证券投资基金(以下简称"本基金")的基 金管理人新疆前海联合基金管理有限公司(以下简称"基金管理人")经与本基金托管人宁波银行股份有 限公司协商一致,决定以通讯方式召开本基金的基金份额持有人大会(以下简称"大会"),审议《关于 持续运作新疆前海联合添泽债券型证券投资基金的议案》。会议的具体安排如下: 1、会议召开方式:通讯方式。 ...
新疆宝地矿业股份有限公司 关于发行股份及支付现金购买资产并募集配套资金暨关联交易相关主体买卖股票情况自查报告的公告
Core Viewpoint - The company is undergoing a significant asset restructuring by acquiring an 82% stake in Xinjiang Congling Energy Co., Ltd. and a 5% stake from JAAN INVESTMENTS CO. LTD. through a combination of cash and stock issuance, while ensuring that no insider trading has occurred during the process [2][14]. Group 1: Transaction Details - The company plans to purchase 82% of Xinjiang Congling Energy Co., Ltd. from Congling Industrial Co., Ltd. and 5% from JAAN INVESTMENTS CO., LTD. [2] - The company will issue shares to raise supporting funds from no more than 35 specific investors, including its controlling shareholder, Xinjiang Geological Mining Investment Group Co., Ltd. [2] Group 2: Insider Trading Investigation - The company conducted a self-examination regarding insider trading, confirming that no insider trading occurred during the investigation period, which spans from six months before the stock suspension request to the day before the disclosure of the transaction report [3][14]. - The investigation included a review of stock trading activities by the company’s directors, supervisors, senior management, and related parties [4][5]. Group 3: Commitments from Individuals - Individuals involved in the transaction provided written commitments stating that their stock trading activities were based on public information and independent judgment, and they did not engage in insider trading [6][8][10]. - The commitments included assurances that they would refrain from trading the company's stock until the transaction is completed or terminated [7][11][12]. Group 4: Independent Advisors' Opinions - The independent financial advisor, Shenwan Hongyuan Securities, confirmed that the stock trading activities of the relevant parties did not constitute insider trading and would not materially affect the restructuring [15]. - The legal advisor, Beijing Deheng Law Firm, also affirmed that the trading activities did not involve insider information and would not impact the transaction [15].
广东利元亨智能装备股份有限公司 关于变更持续督导保荐代表人的公告
Core Viewpoint - The announcement details the change of the continuous supervision sponsor representative for Guangdong Liyuanheng Intelligent Equipment Co., Ltd. from CITIC Securities, ensuring the orderly continuation of supervision work [1]. Group 1: Change of Sponsor Representative - CITIC Securities has issued a letter regarding the replacement of the continuous supervision sponsor representative for the company [1]. - The original representatives were Wang Guowei and Xia Xiaohui, with Xia Xiaohui stepping down due to job changes [1]. - Zheng Xiaoming has been appointed as the new continuous supervision sponsor representative, taking over the responsibilities from Xia Xiaohui [1]. Group 2: Impact on Supervision Work - The change in representatives does not affect the ongoing supervision work by CITIC Securities for the company's initial public offering and convertible bond issuance projects [1]. - The company expresses gratitude to Xia Xiaohui for his contributions during his tenure as the sponsor representative [1]. Group 3: Zheng Xiaoming's Background - Zheng Xiaoming is currently a sponsor representative and registered accountant at CITIC Securities, with a master's degree [2]. - He has participated in various IPO projects, demonstrating a strong background in the field [2]. - Zheng has a good record of compliance with relevant regulations during his practice in sponsorship business [2].
证券代码:688085 证券简称:三友医疗 公告编号:2025-052
Core Viewpoint - Shanghai Sanyou Medical Equipment Co., Ltd. has received approval from the National Medical Products Administration for the JAZZ System spinal internal fixation connector system, marking a significant step in the company's internationalization strategy and enhancing its competitive advantage in the spinal product market [1][3]. Medical Device Registration Details - Product Name: Spinal Internal Fixation Connector System JAZZ System [1] - Registration Number: National Medical Device Registration No. 20253130302 [1] - Registrant: Implanet Company [1] - Agent: Shanghai Sanyou Medical Equipment Co., Ltd. [1] - Applicable Scope: The system is suitable for spinal posterior fixation surgery for thoracolumbar (T1-L5) segments, providing binding fixation for segments unsuitable for pedicle screws [1]. - Registration Validity: From July 10, 2025, to July 9, 2030 [2]. - Composition: The system consists of straps and connectors, sterilized by irradiation with a shelf life of 5 years [2]. Impact on the Company - The introduction of Implanet's advanced JAZZ series products enriches the company's non-fusion spinal product line and enhances its competitive advantage [3]. - The product complements the company's innovative spinal fixation systems, providing a more comprehensive and advanced treatment solution for clinical doctors [3]. - This move is a crucial part of the company's international strategy, successfully bringing Implanet's JAZZ series products to the domestic market, thereby strengthening its market competitiveness and overall strength [3].
招商资管中债1-5年政策性金融债指数证券投资基金基金份额发售公告
Group 1 - The fund is named "Zhaoshang Asset Management China Bond 1-5 Year Policy Financial Bond Index Securities Investment Fund" and is classified as a bond-type securities investment fund [23][24] - The fund will be publicly offered from July 21, 2025, to August 4, 2025, through designated sales institutions, with the possibility of adjusting the fundraising period based on subscription conditions [1][32] - The fund's management company is Zhaoshang Securities Asset Management Co., Ltd., and the custodian is Zhejiang Commercial Bank Co., Ltd. [1][58] Group 2 - The fund offers two classes of shares: Class A shares, which charge subscription fees, and Class C shares, which do not charge subscription fees but deduct service fees from the fund's assets [2][29] - The minimum subscription amount for individual investors is set at 1.00 yuan, and there is no limit on the cumulative subscription scale for individual investors during the fundraising period [8][44] - The fund aims to achieve effective tracking of the benchmark index with minimal tracking deviation and tracking error [25] Group 3 - The fund's investment scope primarily includes the components of the benchmark index and other financial instruments with good liquidity, such as government bonds and policy financial bonds [26] - The fund will not invest in stocks, convertible bonds, or credit bonds, and it must maintain at least 80% of its assets in bond investments [27] - The fund's total minimum subscription amount is set at 200 million shares, with a minimum fundraising amount of 200 million yuan [31]
中兴一沈阳商业大厦(集团)股份有限公司 关于选举第九届董事会职工代表董事的公告
特此公告 中兴一沈阳商业大厦(集团)股份有限公司 董事会 2025年7月16日 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 中兴一沈阳商业大厦(集团)股份有限公司(以下简称"公司")于2025年7月8日召开2025年第二次临时 股东会,审议通过《关于修订〈公司章程〉的议案》。根据《公司章程》有关规定,公司董事会由9名 董事组成,其中职工代表董事1名,由职工代表大会或者其他形式民主选举产生。 公司第四届职工代表大会职工代表组长联席会议于2025年7月14日在公司9楼会议室召开,选举张镝先生 为公司第九届董事会职工代表董事(简历附后)。张镝先生将与公司2025年第三次临时股东会选举产生 的5名非独立董事、3名独立董事共同组成第九届董事会,任期与第九届董事会任期一致。 张镝先生的任职资格符合《公司法》《深圳证券交易所上市公司自律监管指引第1号一主板上市公司规 范运作》《公司章程》等相关规定。本次换届选举后,董事会成员中兼任公司高级管理人员以及由职工 代表担任的董事人数总计未超过公司董事总数的二分之一。 附:第九届 ...
天士力医药集团股份有限公司 第九届董事会第10次会议决议公告
Group 1 - The board of directors of Tianjin Tasly Pharmaceutical Group Co., Ltd. held its 10th meeting of the 9th session on July 14, 2025, with 14 out of 15 directors present, ensuring the meeting's legality and effectiveness [1][2] - The board approved the "Guarantee Management System" with unanimous support, receiving 15 votes in favor and no opposition or abstentions [1] - The "Debt Financing and Liability Management System" was also approved unanimously, with 15 votes in favor and no opposition or abstentions [1] - The performance contract for the company and its management team for 2025 was recognized and approved by the board's nomination, remuneration, and assessment committee prior to the meeting [1] Group 2 - The proposal for senior management compensation and a three-year integration cash incentive plan was approved with 13 votes in favor, with no opposition or abstentions, while related directors recused themselves from the vote [2]